Medical abortion at 64 to 91 days of gestation: a review of 483 consecutive cases.

OBJECTIVE The purpose of this study was to assess the uptake and outcome of medical abortion in the late first trimester of pregnancy. STUDY DESIGN We conducted a review of the cases of 483 consecutive women in a university hospital who underwent medical abortion at 64 to 91 days of gestation and who used mifepristone that was followed 36 to 48 hours later by repeated doses of misoprostol. RESULTS A total of 891 abortions were carried out at 64 to 91 days of gestation from October 2000 to April 2002; of these, 483 cases (54.2%) were undertaken medically. Complete abortion occurred in 458 cases (94.8%). Efficacy decreased with advancing gestational age. Surgical evacuation was carried out in 1 woman (0.9%) at 9 to 10 weeks of gestation, in 8 women (5.3%) at 10 to 11 weeks of gestation, in 7 women (6.2%) at 11 to 12 weeks of gestation, and in 9 women (7.9%) at 12 to 13 weeks of gestation. Indications for surgery included ongoing pregnancy in 8 cases (1.7%), missed abortion in 3 cases (0.6%), incomplete abortion in 13 cases (2.7%), and emergency curettage for bleeding in 1 case (0.2%). The mean number of misoprostol doses used was 2.3; of those women who had a complete abortion, 152 women (32.6%) aborted within 4 hours of receiving the misoprostol. The mean induction to abortion interval was 5.5 hours; most cases (452; 93.6%) were treated as day cases. CONCLUSION Medical abortion between 64 and 91 days of gestation is effective and has a high uptake. Consideration should be given to extending the availability and choice of medical abortion to women in this gestational group.

[1]  A. Templeton,et al.  A randomized comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks gestation. , 2002, Human reproduction.

[2]  H. Helland,et al.  Early pregnancy termination with mifepristone and misoprostol in Norway , 2001, Acta obstetricia et gynecologica Scandinavica.

[3]  M. Creinin,et al.  Mifepristone followed on the same day by vaginal misoprostol for early abortion ∗ ∗ This document includes a discussion of use of a product that is unapproved by the U.S. Food and Drug Administration. , 2001 .

[4]  D. Baird,et al.  Second trimester medical abortion with mifepristone and gemeprost: a review of 956 cases. , 2001, Contraception.

[5]  U. Knudsen.  First trimester abortion with mifepristone and vaginal misoprostol. , 2001, Contraception.

[6]  S. Fielding,et al.  Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial. , 2000, JAMA.

[7]  S. Fielding,et al.  Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. , 2000, Contraception.

[8]  A. Templeton,et al.  Nonsurgical mid‐trimester termination of pregnancy: a review of 500 consecutive cases , 1999, British journal of obstetrics and gynaecology.

[9]  P. Franks,et al.  Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. , 1999, Contraception.

[10]  G. Penney,et al.  An effective regimen for early medical abortion: a report of 2000 consecutive cases. , 1998, Human reproduction.

[11]  A. Templeton,et al.  Termination of pregnancy at 9–13 weeks' amenorrhoea with mifepristone and misoprostol , 1998, The Lancet.

[12]  C. Bardin,et al.  Early pregnancy termination with mifepristone and misoprostol in the United States. , 1998, The New England journal of medicine.

[13]  S. Naji,et al.  Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial , 1997, British journal of obstetrics and gynaecology.

[14]  P. Franks,et al.  Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. , 1997, The Journal of family practice.

[15]  Urquhart,et al.  The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK Multicentre Study--final results. , 1997, Contraception.

[16]  A. Templeton,et al.  Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. , 1995, The New England journal of medicine.

[17]  R. Henshaw,et al.  A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae. , 1994, Human reproduction.

[18]  R. Henshaw,et al.  Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment. , 1993, BMJ.

[19]  D. Baird,et al.  Induction of second trimester abortion with mifepristone and gemeprost , 1993 .